Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction
Mirabel
Prospective Multicentre Non-interventional Comparative Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction
2 other identifiers
observational
2,348
1 country
1
Brief Summary
This is local prospective, non-interventional multi-center comparative study. Primary study objective is evaluation of the user satisfaction with Mirena or Copper IUD up to 1 year after insertion ( patient assessment questionnaire) in daily practice. For each patient, the treating gynecologist documents demographics, medical data, safety parameters and treatment signs and symptoms at an initial visit and one or two follow-up visit(s).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
May 2, 2012
CompletedFirst Posted
Study publicly available on registry
May 3, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2014
CompletedOctober 16, 2015
October 1, 2015
2.5 years
May 2, 2012
October 15, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
User satisfaction of the contraception method with Mirena or Copper IUD
up to 12 months
Secondary Outcomes (4)
Safety evaluation of Mirena or Copper IUD in routine practice Safety parameters include number of AEs, severity,relationship to Mirena or Cooper IUD
up to 12 months
Contraceptive reliability of Mirena or Cooper IUD in routine practice ( fixing number of pregnancies)
up to 12 months
Continuation/discontinuation rate ( number of cases with contraceptive method continuation and discontinuations)
up to 12 months
Relationship between different parameters and women preferences in choosing Mirena or Cooper IUD as their contraceptive method ( demographic parameters, age group, residence, reproductive history and plans, etc.) using patients questionnaire
up to 12 months
Study Arms (2)
Group 1
Group 2
Interventions
intrauterine system containing 52 mg levonorgestrel, with daily release of 20 mcg levonorgestrel
Eligibility Criteria
Females who plan long-term contraception and meet criteria of inclusion and exclusion.
You may qualify if:
- Women 20-40 years old
- Parity ≥ 1 child
- Requesting long-term contraception
- Written informed consent.
You may not qualify if:
- in accordance with the current leaflet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bayerlead
Study Sites (1)
Unknown Facility
Many Locations, Russia
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Bayer Study Director
Bayer
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2012
First Posted
May 3, 2012
Study Start
September 1, 2011
Primary Completion
March 1, 2014
Study Completion
October 1, 2014
Last Updated
October 16, 2015
Record last verified: 2015-10